Helping clinicians treat multidrug-resistant infections
in days, not months
Helping clinicians treat multidrug-resistant infections
in days, not months
Precise Health brings clinicians, patients, phage biobanks, and BioPharma in the fight against multidrug-resistant infections under a unified platform. Our AI-powered platform enables rapid phage matching, sourcing, and in silico engineering—reducing treatment delays and optimizing treatment-ready phage deployment. By connecting global biobanks in a single digital phagogram, we accelerate access to life-saving therapies
Precise Health brings clinicians, patients, phage biobanks, and BioPharma in the fight against multidrug-resistant infections under a unified platform. Our AI-powered platform enables rapid phage matching, sourcing, and in silico engineering—reducing treatment delays and optimizing treatment-ready phage deployment. By connecting global biobanks in a single digital phagogram, we accelerate access to life-saving therapies
We help clinicians access phage therapies in days instead of months through one-click matching, sourcing, and engineering—enabling timely, personalized treatment for drug-resistant infections
Our platform supports you at every step—offering trusted resources, personal guidance, access to phage-treating clinicians, and a community of peers to ensure you're never alone in your treatment journey.
We empower researchers with access to a global phage biobank network and AI tools for in silico engineering—accelerating discovery and translating research into clinical solutions faster.
We help pharma, biotech, and diagnostic companies accelerate precision antimicrobial development through faster phage identification, engineering, and alignment with clinical needs
Instantly match, source, and engineer phages from anywhere. Precise Health’s platform is built for clinicians and researchers—no lab setup or bioinformatics expertise required. Simply submit a bacterial genome to receive AI-guided phage recommendations from a global network of biobanks. Our tools integrate seamlessly into clinical workflows and regulatory pathways, enabling compassionate use or early-phase access with speed and confidence.
Our platform integrates Phage Banks across multiple countries, providing clinicians with access to a broader and more diverse phage API collection. This global integration enables region-specific matching and ensures that, whenever available, treatment-ready phages are prioritized in the recommendations. By connecting biobanks internationally, we accelerate access to targeted therapies and strengthen cross-border collaboration against resistant infections.
Exploring phage therapy can feel overwhelming. That’s why we offer a central, science-based knowledge hub to help patients and caregivers better understand how phage therapy works, what access pathways exist in Europe, and where it is being used.
Our platform also enables patients or caregivers—upon request—to connect with licensed clinicians who are experienced in using phage therapy, in accordance with local regulations. While we do not provide medical advice or treatment, we help individuals find trusted information and guidance toward specialists who can support their journey.
Instantly match, source, and engineer phages from anywhere. Precise Health’s platform is built for clinicians and researchers—no lab setup or bioinformatics expertise required. Simply submit a bacterial genome to receive AI-guided phage recommendations from a global network of biobanks. Our tools integrate seamlessly into clinical workflows and regulatory pathways, enabling compassionate use or early-phase access with speed and confidence.
Our platform integrates Phage Banks across multiple countries, providing clinicians with access to a broader and more diverse phage API collection. This global integration enables region-specific matching and ensures that, whenever available, treatment-ready phages are prioritized in the recommendations. By connecting biobanks internationally, we accelerate access to targeted therapies and strengthen cross-border collaboration against resistant infections.
We deliver patient-grade phage options in days—not weeks—by combining AI prediction, genomic screening, and lab validation. Our tools integrate into clinical workflows and regulatory pathways, enabling compassionate use or early-phase application with minimal friction and maximum confidence.
Phage therapy uses bacteriophages—natural viruses that specifically infect and destroy bacteria—as a targeted alternative to antibiotics. It has been used safely for decades and is gaining renewed global attention as antibiotic resistance rises.
Phage therapy is not broadly approved in most European countries, but it may be accessed under specific frameworks such as compassionate use, early access programs, or magistral preparations. Availability depends on local regulations and the specifics of your case.
You can join our platform to learn more about what may apply in your region.
Unless you are a licensed clinician from an approved hospital – We do not provide phage therapy directly to patients. However, we help patients and caregivers understand available pathways, and—if requested—connect with licensed clinicians who are experienced with phage-based treatments, in accordance with applicable laws.
We maintain a growing network of licensed clinicians who actively work with phage therapy. Upon request, we can help connect you to a relevant specialist, depending on your infection type and location.
Yes. We strictly follow EU GDPR regulations. Any information you share is securely stored and never shared without your explicit consent.
